Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Stefano Rusconi and Paolo Bonfanti.
Stefano Rusconi
Connection Strength
0.324
Paolo Bonfanti
  1. Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir. AIDS. 2017 01 28; 31(3):455-457.
    View in: PubMed
    Score: 0.176
  2. Factors associated with hospital admission for COVID-19 in HIV patients. AIDS. 2020 11 01; 34(13):1983-1985.
    View in: PubMed
    Score: 0.057
  3. Weight Gain: A Possible Side Effect of All Antiretrovirals. Open Forum Infect Dis. 2017; 4(4):ofx239.
    View in: PubMed
    Score: 0.046
  4. Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project. PLoS One. 2017; 12(6):e0179254.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.